Therapy Areas: Oncology
Arbele's ARB1002 receives US FDA Orphan Drug Designation
8 January 2026 - Arbele, a Hong Kong-based biotechnology company focused on developing innovative targeted cancer therapies, announced on Wednesday that it has received Orphan Drug Designation (ODD) f...
GSK reports positive phase III results for bepirovirsen in chronic hepatitis B
7 January 2026 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) on Wednesday reported positive phase III B-Well 1 and B-Well 2 trial results for bepirovirsen, an investigational antisense olig...
Day One completes Mersana acquisition to add rare cancer antibody drug conjugate
6 January 2026 - US-based biopharmaceutical company Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) announced on Tuesday that it has completed its acquisition of Mersana Therapeutics, Inc. (NASDAQ: MR...
Cartography Biosciences partners with Pfizer to discover tumour-selective antigens
6 January 2026 - Biotechnology company Cartography Biosciences Inc announced on Tuesday that it has entered a multi-year collaboration with biopharmaceutical company Pfizer Inc (NYSE:PFE) to discover ...
BostonGene and AstraZeneca collaborate to advance AI-driven oncology development
6 January 2026 - Biomedical software company BostonGene Corporation announced on Tuesday that it has agreed a strategic collaboration with biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN)...
RedHill advances RHB-102 across GI indications
5 January 2026 - Biopharmaceutical company RedHill Biopharma Ltd (Nasdaq: RDHL) revealed on Monday that development of RHB-102 (Bekinda) is progressing across multiple gastrointestinal indications, in...